Tétano

Referências

Principais artigos

Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care. 2014 Mar 26;18(2):217.Texto completo  Resumo

Yen LM, Thwaites CL. Tetanus. Lancet. 2019 Apr 20;393(10181):1657-68. Resumo

Brook I. Current concepts in the management of Clostridium tetani infection. Expert Rev Anti Infect Ther. 2008 Jun;6(3):327-36. Resumo

Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018 Apr 27;67(2):1–44.Texto completo  Resumo

UK Health Security Agency. Tetanus: the green book, chapter 30. Jan 2020 [internet publication].Texto completo

World Health Organization. Tetanus vaccines: WHO position paper – February 2017. Wkly Epidemiol Rec. 2017 Feb 10;92(6):53-76.Texto completo  Resumo

Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2022. Feb 2022 [internet publication].Texto completo

Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Recommended adult immunization schedule for ages 19 years or older, United States, 2022. Feb 2022 [internet publication].Texto completo

Havers FP, Moro PL, Hunter P, et al. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Jan 24;69(3):77-83.Texto completo  Resumo

Tiwari TSP, Moro PL, Acosta AM. Tetanus. In: Hall E, Wodi AP, Hamborsky J, et al, eds. Centers for Disease Control and Prevention. Epidemiology and vaccine-preventable diseases. 14th ed. Washington, D.C.: Public Health Foundation; 2021.Texto completo

Artigos de referência

1. Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care. 2014 Mar 26;18(2):217.Texto completo  Resumo

2. Yen LM, Thwaites CL. Tetanus. Lancet. 2019 Apr 20;393(10181):1657-68. Resumo

3. Ablett JJL. Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit. In: Ellis M, ed. Symposium on tetanus in Great Britain. Boston Spa, UK: National Lending Library; 1967.

4. Brook I. Tetanus in children. Pediatr Emerg Care. 2004 Jan;20(1):48-51. Resumo

5. Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet. 2007 Dec 8;370(9603):1947-59. Resumo

6. Fauveau V, Mamdani M, Steinglass R, et al. Maternal tetanus: magnitude, epidemiology and potential control measures. Int J Gynaecol Obstet. 1993 Jan;40(1):3-12. Resumo

7. Brook I. Current concepts in the management of Clostridium tetani infection. Expert Rev Anti Infect Ther. 2008 Jun;6(3):327-36. Resumo

8. Liang JL, Tiwari T, Moro P, et al. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018 Apr 27;67(2):1–44.Texto completo  Resumo

9. UK Health Security Agency. Tetanus: the green book, chapter 30. Jan 2020 [internet publication].Texto completo

10. Collins S, Amirthalingam G, Beeching NJ, et al. Current epidemiology of tetanus in England, 2001-2014. Epidemiol Infect. 2016 Dec;144(16):3343-53. Resumo

11. Hahne SJM, White JM, Crowcroft NS, et al. Tetanus in injecting drug users, United Kingdom. Emerg Infect Dis. 2006 Apr;12(4):709-10.Texto completo  Resumo

12. UK Health Security Agency. Shooting up: infections among people who inject drugs in the UK. Feb 2022 [internet publication].Texto completo

13. Centers for Disease Control and Prevention. About tetanus. Feb 2019 [internet publication].Texto completo

14. Centers for Disease Control and Prevention (CDC). Tetanus surveillance: United States, 2001-2008. MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):365-9.Texto completo  Resumo

15. Thwaites CL, Farrar JJ. Preventing and treating tetanus. BMJ. 2003 Jan 18;326(7381):117-8.Texto completo  Resumo

16. Kyu HH, Mumford JE, Stanaway JD, et al. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017 Feb 8;17(1):179.Texto completo  Resumo

17. World Health Organization. Maternal and neonatal tetanus elimination (MNTE). Jul 2020 [internet publication].Texto completo

18. Vandelaer J, Birmingham M, Gasse F, et al. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine. 2003 Jul 28;21(24):3442-5. Resumo

19. Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet. 2015 Jan 24;385(9965):362-70. Resumo

20. Kanu FA, Yusuf N, Kassogue M, et al. Progress toward achieving and sustaining maternal and neonatal tetanus elimination - worldwide, 2000-2020. MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):406-11.Texto completo  Resumo

21. Demicheli V, Barale A, Rivetti A. Vaccines for women for preventing neonatal tetanus. Cochrane Database Syst Rev. 2015;(7):CD002959.Texto completo  Resumo

22. Farrar JJ, Yen LM, Cook T, et al. Tetanus. J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):292-301.Texto completo  Resumo

23. Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992 Oct 29;359(6398):832-5. Resumo

24. Reid PM, Brown D, Coni N, et al. Tetanus immunisation in the elderly population. J Accid Emerg Med. 1996 May;13(3):184-5.Texto completo  Resumo

25. Yen LM, Dao LM, Day NP, et al. Role of quinine in the high mortality of intramuscular injection tetanus. Lancet. 1994 Sep 17;344(8925):786-7. Resumo

26. Udwadia FE. Tetanus. New York, NY: Oxford University Press; 1994.

27. World Health Organization. Tetanus vaccines: WHO position paper – February 2017. Wkly Epidemiol Rec. 2017 Feb 10;92(6):53-76.Texto completo  Resumo

28. Centers for Disease Control and Prevention. CDC health information for international travel (yellow book): tetanus. 2020 [internet publication].Texto completo

29. Public Health England. Advice on tetanus for people who inject drugs. May 2013 [internet publication].Texto completo

30. Blencowe H, Lawn J, Vandelaer J, et al. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010 Apr;39(Suppl 1):i102-9.Texto completo  Resumo

31. Committee on Obstetric Practice, Immunization and Emerging Infections Expert Work Group. Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Obstet Gynecol. 2017 Sep;130(3):e153-7.Texto completo  Resumo

32. Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health. 2011 Apr 13;11(Suppl 3):S11.Texto completo  Resumo

33. Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2022. Feb 2022 [internet publication].Texto completo

34. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Recommended adult immunization schedule for ages 19 years or older, United States, 2022. Feb 2022 [internet publication].Texto completo

35. Havers FP, Moro PL, Hunter P, et al. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Jan 24;69(3):77-83.Texto completo  Resumo

36. Oliver SE, Moore KL. Licensure of a diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine, and guidance for use in infants. MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):136-9.Texto completo  Resumo

37. Tiwari TSP, Moro PL, Acosta AM. Tetanus. In: Hall E, Wodi AP, Hamborsky J, et al, eds. Centers for Disease Control and Prevention. Epidemiology and vaccine-preventable diseases. 14th ed. Washington, D.C.: Public Health Foundation; 2021.Texto completo

38. Public Health England. Tetanus: advice for health professionals. Jul 2019 [internet publication].Texto completo

39. Schon F, O'Dowd L, White J, et al. Tetanus: delay in diagnosis in England and Wales. J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):1006-7.Texto completo  Resumo

40. Crone NE, Reder AT. Severe tetanus in immunized patients with high anti-tetanus titers. Neurology. 1992 Apr;42(4):761-4. Resumo

41. Rushdy AA, White JM, Ramsay ME, et al. Tetanus in England and Wales, 1984-2000. Epidemiol Infect. 2003 Feb;130(1):71-7. Resumo

42. Wood D, Webster E, Martinez D, et al. Case report: survival after deliberate strychnine self-poisoning, with toxicokinetic data. Crit Care. 2002 Oct;6(5):456-9.Texto completo  Resumo

43. Nakajima M, Aso S, Matsui H, et al. Clinical features and outcomes of tetanus: Analysis using a National Inpatient Database in Japan. J Crit Care. 2018 Apr;44:388-91. Resumo

44. Campbell JI, Lam TM, Huynh TL, et al. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg. 2009 May;80(5):827-31.Texto completo  Resumo

45. Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed). 1985 Sep 7;291(6496):64.Texto completo  Resumo

46. Yen LM, Dao LM, Day NPJ, et al. Management of tetanus: a comparison of penicillin and metronidazole. Paper presented at: Symposium of antimicrobial resistance in southern Viet Nam; 1997; Ho Chi Minh City, Vietnam.

47. Kapoor W, Carey P, Karpf M. Induction of lactic acidosis with intravenous diazepam in a patient with tetanus. Arch Intern Med. 1981 Jun;141(7):944-5. Resumo

48. Attygalle D, Rodrigo N. New trends in the management of tetanus. Expert Rev Anti Infect Ther. 2004 Feb;2(1):73-84. Resumo

49. Gyasi HK, Fahr J, Kurian E, et al. Midazolam for prolonged intravenous sedation in patients with tetanus. Middle East J Anesthesiol. 1993 Jun;12(2):135-41. Resumo

50. Okoromah CN, Lesi FE. Diazepam for treating tetanus. Cochrane Database Syst Rev. 2004 Jan 26;(1):CD003954. Resumo

51. Buchanan N, Cane RD, Wolfson G, et al. Autonomic dysfunction in tetanus: the effects of a variety of therapeutic agents, with special reference to morphine. Intensive Care Med. 1979 May;5(2):65-8. Resumo

52. Engrand N, Vilain G, Rouamba A, et al. Value of intrathecal baclofen in the treatment of severe tetanus in the tropical milieu. Med Trop (Mars). 2000;60(4):385-8. [In French] Resumo

53. Saissy JM, Demaziere J, Vitris M, et al. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med. 1992;18(4):241-4. Resumo

54. Boots RJ, Lipman J, O'Callaghan J, et al. The treatment of tetanus with intrathecal baclofen. Anaesth Intensive Care. 2000 Aug;28(4):438-42. Resumo

55. Dressnandt J, Konstanzer A, Weinzierl FX, et al. Intrathecal baclofen in tetanus: four cases and a review of reported cases. Intensive Care Med. 1997 Aug;23(8):896-902. Resumo

56. Santos ML, Mota-Miranda A, Alves-Pereira A, et al. Intrathecal baclofen for the treatment of tetanus. Clin Infect Dis. 2004 Feb 1;38(3):321-8.Texto completo  Resumo

57. Lee C, Zhang X, Kwan WF. Electromyographic and mechanomyographic characteristics of neuromuscular block by magnesium sulphate in the pig. Br J Anaesth. 1996 Feb;76(2):278-83.Texto completo  Resumo

58. James MFM, Manson EDM. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med. 1985;11(1):5-12. Resumo

59. Lipman J, James MFM, Erskine J, et al. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med. 1987 Oct;15(10):987-8. Resumo

60. Attygalle D, Rodrigo N. Magnesium sulphate for control of spasms in severe tetanus. Can we avoid sedation and artificial ventilation? Anaesthesia. 1997 Oct;52(10):956-62. Resumo

61. Thwaites CL, Yen LM, Loan HT, et al. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet. 2006 Oct 21;368(9545):1436-43. Resumo

62. Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: a prospective study of 40 patients. Anaesthesia. 2002 Aug;57(8):811-7. Resumo

63. Rodrigo C, Samarakoon L, Fernando SD, et al. A meta-analysis of magnesium for tetanus. Anaesthesia. 2012 Dec;67(12):1370-4. Resumo

64. Rocke DA, Wesley AG, Pather M, et al. Morphine in tetanus--the management of sympathetic nervous system overactivity. S Afr Med J. 1986 Nov 22;70(11):666-8. Resumo

65. Buchanan N, Smit L, Cane RD, et al. Sympathetic overactivity in tetanus: fatality associated with propranolol. Br Med J. 1978 Jul 22;2(6132):254-5.Texto completo  Resumo

66. Dolar D. The use of continuous atropine infusion in the management of tetanus. Intensive Care Med. 1992;18(1):26-31. Resumo

67. Sutton DN, Tremlett MR, Woodcock TE, et al. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med. 1990;16(2):75-80. Resumo

68. Gregorakos L, Kerezoudi E, Dimopoulos G, et al. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997 Aug;23(8):893-5. Resumo

69. Southorn PA, Blaise GA. Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade. Crit Care Med. 1986 Mar;14(3):251-2. Resumo

70. Shibuya M, Sugimoto H, Sugimoto T, et al. The use of continuous spinal anesthesia in severe tetanus with autonomic disturbance. J Trauma. 1989 Oct;29(10):1423-9. Resumo

71. Freshwater-Turner D, Udy A, Lipman J, et al. Autonomic dysfunction in tetanus - what lessons can be learnt with special reference to alpha-2 agonists? Anaesthesia. 2007 Oct;62(10):1066-70. Resumo

72. Wesley AG, Hariparsad D, Pather M, et al. Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia. 1983 Mar;38(3):243-9. Resumo

73. King WW, Cave DR. Use of esmolol to control autonomic instability of tetanus. Am J Med. 1991 Oct;91(4):425-8. Resumo

74. Beards SC, Lipman J, Bothma PA, et al. Esmolol in a case of severe tetanus. Adequate haemodynamic control achieved despite markedly elevated catecholamine levels. S Afr J Surg. 1994 Mar;32(1):33-5. Resumo

75. Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel). 2013 Jan 8;5(1):73-83.Texto completo  Resumo

76. Loan HT, Yen LM, Kestelyn E, et al. A pilot study to assess safety and feasibility of intrathecal immunoglobulin for the treatment of adults with tetanus. Am J Trop Med Hyg. 2018 Aug;99(2):323-6.Texto completo  Resumo

77. Loan HT, Yen LM, Kestelyn E, et al. Intrathecal immunoglobulin for treatment of adult patients with tetanus: a randomized controlled 2x2 factorial trial. Wellcome Open Res. 2018 Nov 5;3:58.Texto completo  Resumo

78. Thwaites CL, Yen LM, Glover C, et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Trop Med Int Health. 2006 Mar;11(3):279-87.Texto completo  Resumo

79. Phillips LA. A classification of tetanus. Lancet. 1967 Jun 3;1(7501):1216-7. Resumo

80. Vakil BJ. Table ronde: propositions pour une classification internationale. In: 4th International Conference on Tetanus, vol 1. Dakar, Senegal: Fondation Merieux; 1975:3349-67.

81. Gurses N, Aydin M. Factors affecting prognosis of neonatal tetanus. Scan J Infect Dis. 1993;25(3):353-5. Resumo

82. Davies-Adetugbo AA, Torimiro SE, Ako-Nai KA. Prognostic factors in neonatal tetanus. Trop Med Int Health. 1998 Jan;3(1):9-13.Texto completo  Resumo

83. Basu S, Paul DK, Ganguly S, et al. Risk factors for mortality from neonatal tetanus: 7 years experience in North Bengal, India. Ann Trop Paediatr. 2006 Sep;26(3):233-9. Resumo

84. Lam PK, Trieu HT, Lubis IN, et al. Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants. Int J Infect Dis. 2015 Apr;33:7-11.Texto completo  Resumo

85. Loan HT, Parry J, Nga NT, et al. Semi-recumbent body position fails to prevent healthcare-associated pneumonia in Vietnamese patients with severe tetanus. Trans R Soc Trop Med Hyg. 2012 Feb;106(2):90-7.Texto completo  Resumo

86. Chalya PL, Mabula JB, Dass RM, et al. Ten-year experiences with tetanus at a tertiary hospital in northwestern Tanzania: a retrospective review of 102 cases. World J Emerg Surg. 2011 Jul 8;6:20.Texto completo  Resumo

87. Teknetzi P, Manios S, Katsouyanopoulos V. Neonatal tetanus--long-term residual handicaps. Arch Dis Child. 1983 Jan;58(1):68-9.Texto completo  Resumo

88. Anlar B, Yalaz K, Dizmen R. Long-term prognosis after neonatal tetanus. Dev Med Child Neurol. 1989 Feb;31(1):76-80. Resumo

89. Barlow JL, Mung'Ala-Odera V, Gona J, et al. Brain damage after neonatal tetanus in a rural Kenyan hospital. Trop Med Int Health. 2001 Apr;6(4):305-8.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal